Literature DB >> 16132356

Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses.

Matthew S Coates1, Hak-Kim Chan, David F Fletcher, Judy A Raper.   

Abstract

PURPOSE: The aims of the study are to analyze the influence of air flow on the overall performance of a dry powder inhaler (Aerolizer and to provide an initial quantification of the flow turbulence levels and particle impaction velocities that maximized the inhaler dispersion performance.
METHODS: Computational fluid dynamics (CFD) analysis of the flow field in the Aerolizer, in conjunction with experimental dispersions of mannitol powder using a multistage liquid impinger, was used to determine how the inhaler dispersion performance varied as the device flow rate was increased.
RESULTS: Both the powder dispersion and throat deposition were increased with air flow. The capsule retention was decreased with flow, whereas the device retention first increased then decreased with flow. The optimal inhaler performance was found at 65 l min(-1) showing a high fine particle fraction (FPF) of 63 wt.% with low throat deposition (9.0 wt.%) and capsule retention (4.3 wt.%). Computational fluid dynamics analysis showed that at the critical flow rate of 65 l min(-1), the volume-averaged integral scale strain rate (ISSR) was 5,400 s(-1), and the average particle impaction velocities were 12.7 and 19.0 m s(-1) at the inhaler base and grid, respectively. Correlations between the device flow rate and (a) the amount of throat deposition and (b) the capsule emptying times were also developed.
CONCLUSIONS: The use of CFD has provided further insight into the effect of air flow on the performance of the Aerolizer. The approach of using CFD coupled with powder dispersion is readily applicable to other dry powder inhalers (DPIs) to help better understand their performance optimization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132356     DOI: 10.1007/s11095-005-6155-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Computer simulation of the packing of fine particles

Authors: 
Journal:  Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics       Date:  2000-09

2.  Deagglomeration of dry powder pharmaceutical aerosols.

Authors:  Austin Voss; Warren H Finlay
Journal:  Int J Pharm       Date:  2002-11-06       Impact factor: 5.875

3.  Deposition of Foradil P in human lungs: comparison of in vitro and in vivo data.

Authors:  T Meyer; P Brand; H Ehlich; R Köbrich; G Meyer; F Riedinger; K Sommerer; T Weuthen; G Scheuch
Journal:  J Aerosol Med       Date:  2004

4.  Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length.

Authors:  Matthew S Coates; David F Fletcher; Hak-Kim Chan; Judy A Raper
Journal:  J Pharm Sci       Date:  2004-11       Impact factor: 3.534

5.  Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders.

Authors:  N Y Chew; D F Bagster; H K Chan
Journal:  Int J Pharm       Date:  2000-09-25       Impact factor: 5.875

6.  Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol.

Authors:  J D Brannan; S D Anderson; K Gomes; G G King; H K Chan; J P Seale
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

7.  In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler.

Authors:  N Y Chew; H K Chan
Journal:  J Aerosol Med       Date:  2001

8.  Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.

Authors:  Evangelia Daviskas; Sandra D Anderson; Kerry Gomes; Peter Briffa; Belinda Cochrane; H-Kim Chan; Iven H Young; Bruce K Rubin
Journal:  Respirology       Date:  2005-01       Impact factor: 6.424

9.  Novel system to investigate the effects of inhaled volume and rates of rise in simulated inspiratory air flow on fine particle output from a dry powder inhaler.

Authors:  Varsha Chavan; Richard Dalby
Journal:  AAPS PharmSci       Date:  2002

Review 10.  Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction.

Authors:  Evangelia Daviskas; Michael Robinson; Sandra D Anderson; P T P Bye
Journal:  J Aerosol Med       Date:  2002
View more
  28 in total

1.  Effects of device and formulation on in vitro performance of dry powder inhalers.

Authors:  Wallace P Adams; Sau L Lee; Robert Plourde; Robert A Lionberger; Craig M Bertha; William H Doub; Jean-Marc Bovet; Anthony J Hickey
Journal:  AAPS J       Date:  2012-04-05       Impact factor: 4.009

2.  Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers.

Authors:  Jagdeep Shur; Sau Lee; Wallace Adams; Robert Lionberger; James Tibbatts; Robert Price
Journal:  AAPS J       Date:  2012-06-22       Impact factor: 4.009

3.  Particle aerosolisation and break-up in dry powder inhalers 1: evaluation and modelling of venturi effects for agglomerated systems.

Authors:  William Wong; David F Fletcher; Daniela Traini; Hak-Kim Chan; John Crapper; Paul M Young
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

4.  Use of Computational Fluid Dynamics (CFD) Dispersion Parameters in the Development of a New DPI Actuated with Low Air Volumes.

Authors:  Worth Longest; Dale Farkas; Karl Bass; Michael Hindle
Journal:  Pharm Res       Date:  2019-05-28       Impact factor: 4.200

5.  Influence of mouthpiece geometry on the aerosol delivery performance of a dry powder inhaler.

Authors:  Matthew S Coates; Hak-Kim Chan; David F Fletcher; Herbert Chiou
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

6.  Multi-scale modelling of powder dispersion in a carrier-based inhalation system.

Authors:  Zhenbo Tong; Hidehiro Kamiya; Aibing Yu; Hak-Kim Chan; Runyu Yang
Journal:  Pharm Res       Date:  2014-12-17       Impact factor: 4.200

7.  Effect of device design on the aerosolization of a carrier-based dry powder inhaler--a case study on Aerolizer(®) Foradile (®).

Authors:  Qi Tony Zhou; Zhenbo Tong; Patricia Tang; Mauro Citterio; Runyu Yang; Hak-Kim Chan
Journal:  AAPS J       Date:  2013-02-01       Impact factor: 4.009

Review 8.  Advances in device and formulation technologies for pulmonary drug delivery.

Authors:  John Gar Yan Chan; Jennifer Wong; Qi Tony Zhou; Sharon Shui Yee Leung; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2014-04-12       Impact factor: 3.246

9.  Investigation of electrostatic behavior of a lactose carrier for dry powder inhalers.

Authors:  Keat Theng Chow; Kewu Zhu; Reginald B H Tan; Paul W S Heng
Journal:  Pharm Res       Date:  2008-06-26       Impact factor: 4.200

10.  Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols.

Authors:  P Worth Longest; Yoen-Ju Son; Landon Holbrook; Michael Hindle
Journal:  Pharm Res       Date:  2013-03-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.